Has Patrick St Pierre, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,718,204 in general payments to Patrick St Pierre, MD across 366 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Patrick St Pierre, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Patrick St Pierre, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Patrick St Pierre, MD

Orthopaedic Surgery · Rancho Mirage, CANPI 1548225931

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,451,233 of the $1,718,204 with a category attached, or 84.5%. Encore Medical, LP accounts for 83.5% of it on its own, with 11 other manufacturers making up the rest. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,718,204in general payments, 2019–2025

Across 366 payments — averaging $4694.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Encore Medical, LP$1.4M
Stryker$208K
Zimmer Biomet$56K
Linvatec Corporation$13K
Empire Medical, Inc$3K
Arthrex$1K
plus $2K from 6 others

$17,475in research payments, 2019–2025

Across 12 payments — averaging $1456.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$16K
Conventus Orthopaedics, Inc.$2K

What the payments were for

Royalty or licence$1,451,23384%
Consulting fees$224,11513%
Speaking & faculty fees$500%
Travel & lodging$29,2942%
Food & beverage$11,1121%
Education$2,4000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Encore Medical, LP	65	$1,435,491
Stryker	213	$207,812
Zimmer Biomet	36	$56,037
Linvatec Corporation	19	$13,425
Empire Medical, Inc	2	$2,594
Arthrex	15	$1,322
Biorez, Inc.	3	$914
Aesculap Biologics, LLC	3	$182
DJO, LLC	4	$159
BREG, Inc	1	$114
Pacira Therapeutics, Inc.	2	$86
Bioventus LLC	3	$67

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO SURGICAL$975,491
DJO Surgical AltiVate Reverse$459,405
MAKO$152,049
BioWick X$35,165
REUNION$21,560
TRIATHLON$13,375
DJO Surgical AltiVate Anatomic System$12,820
Biowick$11,978
Expressbraid$7,625
AC Joint Ziptight$7,625
Charlote Shoulder Instr$7,625
BioBrace 23mm$6,892
BIOBRACE$6,850
TORNIER PERFORM REVERSED GLENOID$4,749
BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$4,313
AEQUALIS$4,000
AEQUALIS PERFORM$2,978
AEQUALIS PERFORM REVERSED$2,649
DJO Surgical Match Point System$1,120
Juggerknot$997

How this compares

$1,718,204 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$367,291

Medicare patients

635

Services billed

1,779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	91	$3,381
Meloxicam	51	$120

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rancho Mirage

Erik SchnaserRancho Mirage$948K
Bradford HackArcadia$18.3M
Robert GorabOrange$13.6M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M
Thomas CoonRed Bluff$9.2M
Nirav AminPlacentia$5.6M
Tom NorrisSan Francisco$5.3M
Jay LiebermanLos Angeles$4.8M
Peter NewtonSan Diego$4.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →